New research suggests that GLP-1 drugs like Ozempic and Wegovy, commonly used for diabetes and weight loss, may also reduce the risk of Alzheimer's disease and dementia.

Dr. Daniel Drucker shares the US$3 million prize with four colleagues in the U.S. and Denmark for discovering the GLP-1 hormone that's used in medications like Ozempic.

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Dr. Daniel Drucker, an endocrinologist and a clinician-scientist at the University of Toronto and the Lunenfeld-Tanenbaum ...

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...

THE Simpsons fans have been left stunned as the show’s iconic twins Patty and Selma Bouvier have undergone a shock ‘Ozempic ...

A slimmed-down former congresswoman sparked Ozempic rumors as she shared a clip of herself scathing President Trump's tariff ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity ... British Columbia, Canada. Overall, semaglutide users were 50% more likely to experience hair loss compared to ...

Semaglutide medications like Ozempic and Wegovy have exploded in popularity ... British Columbia, Canada. "There were [previous] anecdotal reports of hair loss and also reports of hair loss ...